Pharmaceutical Supply Chain Management Market: Leading SCM Solutions Supply chain management (SCM) entails the successful administration of supply chain operations designed to increase profits and provide a better customer experience. The process also ensures that products are manufactured as planned and become available in hospitals, pharmacies, and other health services on time. According to Inkwood Research, the global pharmaceutical supply chain management market is projected to progress with a CAGR of 8.84% between 2023 to 2032, capturing a revenue share of $5289.53 by 2032.
The success of a manufacturing organization depends greatly on the efficacy of the supply chain as a whole. If a certain link in the chain is disrupted or weak, it could jeopardize the entire chain. Supply chain management, in this regard, is essential to help organizations remain agile, while handling unexpected issues or variability that may occur. By streamlining supply chain processes and increasing visibility, pharmaceutical businesses can diagnose problems and find suitable solutions more swiftly. According to Inkwood Research, the solution segment is set to grow with a CAGR of 8.67% between 2023 to 2032. An effective and streamlined pharmaceutical supply chain includes the implementation of various strategies as well as technologies in order to provide customers with unique added value. Aligning with this, this blog explores how leading companies are focusing on the development of advanced technologies to enhance pharmaceutical supply chains globally –
Infor Cloverleaf® Integration Suite – The Infor Cloverleaf® Integration Suite streamlines clinical data exchange to enhance business operations and medical outcomes. Utilized by more than 1/3 of hospitals in the United States and deployed in 36 nations, the software